Previous close | 1.5800 |
Open | 1.5700 |
Bid | 1.5500 x 400 |
Ask | 1.5900 x 100 |
Day's range | 1.5100 - 1.6593 |
52-week range | 0.8910 - 2.6000 |
Volume | |
Avg. volume | 317,260 |
Market cap | 80.143M |
Beta (5Y monthly) | 1.95 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Personalis Inc (PSNL) reports a robust Q1 with significant revenue growth and strategic developments in biopharma collaborations and product launches.
Personalis, Inc. (NASDAQ:PSNL) Q4 2023 Earnings Call Transcript February 28, 2024 Personalis, Inc. misses on earnings expectations. Reported EPS is $-0.54 EPS, expectations were $-0.53. PSNL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Personalis […]
Personalis, Inc. ( NASDAQ:PSNL ) shares have had a really impressive month, gaining 37% after a shaky period...